EUVIMEDScopri EUVIMED
Open access

A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer

Xiaolu Hu, Xiaoyu Yang, Peng Jin, Jiaxin Tian, Chuntao Tao, Yishu Tang, Ying Zhang iD

Molecular Carcinogenesis · 2026-08 · 65 (8) · 938-947

DOI: 10.1002/mc.70124 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-05-15. Written by Xiaolu Hu and 6 co-authors. Institution: The First Clinical College, Chongqing Medical University, Chongqing, China. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Lung Neoplasms, RNA, Transfer. 63 references. The full text is freely available in PubMed Central. Funded by: Chongqing Natural Science Foundation, Chongqing Municipal Training Program of Innovation and Entrepreneurship for Undergraduates.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

As a promising candidate in liquid biopsy, tRNA‐derived small RNAs (tsRNAs) have been implicated as potential diagnostic biomarkers for cancer; however, the diagnostic potential of serum cell‐free tsRNAs in non‐small cell lung cancer (NSCLC) remains unexplored. This study aimed to develop a combinatorial model based on serum cell‐free tsRNA signatures and evaluated its diagnostic performance for NSCLC detection. Through systematic screening from the tsRFun database, we identified 32 NSCLC‐related differentially expressed tsRNAs, whose predicted target genes were significantly enriched in the MAPK pathway. Four MAPK pathway‐associated tsRNAs were selected for further validation due to their robust discriminatory power in distinguishing NSCLC patients from healthy control. Subsequent validation via quantitative RT‐PCR confirmed significantly elevated serum levels of tsRNA‐Thr‐5‐0039, tsRNA‐Thr‐5‐0044, and tsRNA‐Cys‐5‐0011 in NSCLC patients compared to healthy controls. The final combinatorial diagnostic model incorporating these three tsRNAs achieved an AUC of 0.83 (95% CI: 0.70–0.95), with 71.8% accuracy, 52.6% sensitivity, and 90.0% specificity. The three‐tsRNA model outperformed individual tsRNAs in diagnostic efficiency. In conclusion, these findings highlight the diagnostic potential of circulating tsRNA signatures as a minimally invasive liquid biopsy approach, offering new perspectives for early diagnosis of NSCLC.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungBiomarkers, TumorLung NeoplasmsRNA, TransferCell-Free Nucleic AcidsHumansFemaleMaleLiquid BiopsyMiddle AgedCase-Control StudiesGene Expression Regulation, Neoplastic

Author keywords

diagnostic biomarkerliquid biopsynon‐small cell lung cancertsRNA

Substances

Biomarkers, TumorRNA, TransferCell-Free Nucleic Acids

Authors and institutions

  • The First Clinical College, Chongqing Medical University, Chongqing, China.
  • The Second Clinical College, Chongqing Medical University, Chongqing, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID profiles: Ying Zhang

Funding

  • Chongqing Natural Science Foundation
  • Chongqing Municipal Training Program of Innovation and Entrepreneurship for Undergraduates

Cite

APA

Hu, X., Yang, X., Jin, P., Tian, J., Tao, C., Tang, Y., & Zhang, Y. (2026). A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer. Molecular Carcinogenesis, 65(8), 938-947. https://doi.org/10.1002/mc.70124

Vancouver

Hu X, Yang X, Jin P, Tian J, Tao C, Tang Y, et al. A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer. Molecular Carcinogenesis. 2026;65(8):938-947. doi:10.1002/mc.70124

BibTeX
@article{Hu2026,
  author = {Hu, Xiaolu and Yang, Xiaoyu and Jin, Peng and Tian, Jiaxin and Tao, Chuntao and Tang, Yishu and Zhang, Ying},
  title = {A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {8},
  pages = {938--947},
  doi = {10.1002/mc.70124}
}
Start for free →